NM_002292.4:c.1891-11C>T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong
The NM_002292.4(LAMB2):c.1891-11C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000452 in 1,614,214 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.000066   (  0   hom.,  cov: 33) 
 Exomes 𝑓:  0.000043   (  0   hom.  ) 
Consequence
 LAMB2
NM_002292.4 intron
NM_002292.4 intron
Scores
 2
 Splicing: ADA:  0.00002142  
 2
Clinical Significance
Conservation
 PhyloP100:  -1.39  
Publications
0 publications found 
Genes affected
 LAMB2  (HGNC:6487):  (laminin subunit beta 2) Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins, composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively), form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the beta chain isoform laminin, beta 2. The beta 2 chain contains the 7 structural domains typical of beta chains of laminin, including the short alpha region. However, unlike beta 1 chain, beta 2 has a more restricted tissue distribution. It is enriched in the basement membrane of muscles at the neuromuscular junctions, kidney glomerulus and vascular smooth muscle. Transgenic mice in which the beta 2 chain gene was inactivated by homologous recombination, showed defects in the maturation of neuromuscular junctions and impairment of glomerular filtration. Alternative splicing involving a non consensus 5' splice site (gc) in the 5' UTR of this gene has been reported. It was suggested that inefficient splicing of this first intron, which does not change the protein sequence, results in a greater abundance of the unspliced form of the transcript than the spliced form. The full-length nature of the spliced transcript is not known. [provided by RefSeq, Aug 2011] 
LAMB2 Gene-Disease associations (from GenCC):
- Pierson syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, PanelApp Australia, Orphanet
- LAMB2-related infantile-onset nephrotic syndromeInheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91). 
BP6
Variant 3-49128596-G-A is Benign according to our data. Variant chr3-49128596-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 258601.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000591  AC: 9AN: 152226Hom.:  0  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
9
AN: 
152226
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0000756  AC: 19AN: 251376 AF XY:  0.000118   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
19
AN: 
251376
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000431  AC: 63AN: 1461870Hom.:  0  Cov.: 30 AF XY:  0.0000550  AC XY: 40AN XY: 727230 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
63
AN: 
1461870
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
40
AN XY: 
727230
show subpopulations 
African (AFR) 
 AF: 
AC: 
2
AN: 
33480
American (AMR) 
 AF: 
AC: 
0
AN: 
44724
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1
AN: 
26136
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39700
South Asian (SAS) 
 AF: 
AC: 
41
AN: 
86252
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53404
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
15
AN: 
1112012
Other (OTH) 
 AF: 
AC: 
4
AN: 
60394
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.488 
Heterozygous variant carriers
 0 
 6 
 12 
 17 
 23 
 29 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000656  AC: 10AN: 152344Hom.:  0  Cov.: 33 AF XY:  0.0000671  AC XY: 5AN XY: 74500 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
10
AN: 
152344
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
5
AN XY: 
74500
show subpopulations 
African (AFR) 
 AF: 
AC: 
4
AN: 
41578
American (AMR) 
 AF: 
AC: 
0
AN: 
15306
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5194
South Asian (SAS) 
 AF: 
AC: 
2
AN: 
4830
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10626
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
3
AN: 
68016
Other (OTH) 
 AF: 
AC: 
1
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.475 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Pierson syndrome;C3280113:LAMB2-related infantile-onset nephrotic syndrome    Benign:1 
Mar 18, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 dbscSNV1_ADA 
 Benign 
 dbscSNV1_RF 
 Benign 
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.